Katerina S. Papacosma

Katerina graduated from Boston University School of Law, where she was the executive editor of the American Journal of Law & Medicine, vice president of the International Law Society, and alumni chair of the Women’s Law Association. During law school, Katerina served as a law clerk in the Civil Division of the US Department of Justice United States Attorney’s Office for the District of Massachusetts.  She also spent a semester working for the Joint Committee on Financial Services at the Massachusetts State House.

As an undergraduate, Katerina spent a semester abroad working for the United Nations in Geneva, Switzerland, focusing on human rights and the implementation of the Convention on the Rights of the Child. She also interned for a PAC in Washington, DC.

Katerina is fluent in French and Greek.

• Represented abeo Management Corporation, through its wholly owned subsidiary Genascis, LLC, in its acquisition of the ambulatory surgical care division of Surgical Synergies, Inc.
• Represented Acme Packet, Inc. in connection with its $2.1 billion acquisition by Oracle
• Represented Agero, Inc. in the sale of its connected vehicle services division to Sirius XM Radio Inc. for $530 million in cash, and in its acquisition of MBSi Capital Corp.
• Represented Argyle Executive Forum, LLC in its sale to private equity firm The Wicks Group of Companies
• Represented Blue Bell Mattress Company in a transaction involving a leveraged recapitalization and the acquisition of a 70 percent equity interest in Blue Bell by private equity firm Longroad Asset Management, a deal nominated by The M&A Advisor and ACG New York as a finalist for “Manufacturing Deal of the Year,” “Consumer Deal of the Year,” and “Leveraged Buyout of the Year,” and selected as “Leveraged Buyout of the Year”
• Represented private equity firm Bunker Hill Capital in its acquisitions of Vesta Partners, US and its foreign subsidiaries, Dyno Merchandise and its domestic and foreign companies, Hubbardton Forge, ASPEQ Heating Group, and Taos Mountain. Also represented Bunker Hill Capital in its sales of SunBrite TV, California Family Fitness, and the Smith & Wollensky Restaurant Group
• Represented Financial Recovery Technologies LLC in its acquisition of IRSS LLC
• Represented MedVentive, Inc. in its sale to McKesson Corporation (NYSE: MCK)
• Represented Rhythm in its filings with the US Securities and Exchange Commission related to its proposed initial public offering
• Represented Rhythm and its wholly owned subsidiary Rhythm Pharmaceuticals, Inc. in its grant of an exclusive option to be acquired by Actavis plc
• Represented Tempur-Pedic International, Inc. in its $1.3 billion merger to acquire Sealy Corporation
• Represented Waters Corporation in its acquisition of Blue Reference, Inc.
• Represented private equity firm The Wicks Group of Companies in its disposition of The Gordian Group to Warburg Pincus, LLC
• Represented private equity firm The Wicks Group of Companies in its leveraged acquisition of Northstar Travel Media and subsequent disposition to Wasserstein Partners, its leveraged acquisitions of the assets of McMurry, Inc., The Magazine Group, Inc. (TMG Custom Media), and Manifest Digital, three previously unrelated content-marketing companies, and the combination of the three businesses into Manifest LLC, and its acquisition of Bisnow, LLC
• Represented private equity firm The Wicks Group of Companies and its portfolio company Northstar Travel Media in the acquisitions of Thomas, Townsend and Kent Inc. (d/b/a Your Travel Insider), the China and Singapore assets of Contineo Media, the Singapore assets of Wired Ventures Pte. Ltd. (Web in Travel), Resort Industry Marketing, LLC (Mountain Travel Symposium), and Sterling Valley Systems, Inc. (d/b/a Inntopia) and its domestic and foreign subsidiaries
• Venture Capital Financings — Represented multiple privately held growth companies in venture capital financing transactions and with general corporate matters, including IDSS Holdings, Inc., Life Image Inc., Pragya Systems Corp., Rhythm Pharmaceuticals, Stemgent, Inc., and VaxInnate Corporation
• Ongoing representation of several private equity sponsors and venture capital firms in connection with portfolio company acquisitions and investments